CA3072861C - Composes d'azaindolylpyridone et de diazaindolylpyridone - Google Patents

Composes d'azaindolylpyridone et de diazaindolylpyridone

Info

Publication number
CA3072861C
CA3072861C CA3072861A CA3072861A CA3072861C CA 3072861 C CA3072861 C CA 3072861C CA 3072861 A CA3072861 A CA 3072861A CA 3072861 A CA3072861 A CA 3072861A CA 3072861 C CA3072861 C CA 3072861C
Authority
CA
Canada
Prior art keywords
pyridin
trifluoromethyl
pyrrolo
pharmaceutically acceptable
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3072861A
Other languages
English (en)
Other versions
CA3072861A1 (fr
Inventor
Johan Lindstrom
Rickard FORSBLOM
Fredrik Rahm
Jenny Viklund
Original Assignee
Sprint Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sprint Bioscience AB filed Critical Sprint Bioscience AB
Priority claimed from PCT/EP2018/072785 external-priority patent/WO2019038384A1/fr
Publication of CA3072861A1 publication Critical patent/CA3072861A1/fr
Application granted granted Critical
Publication of CA3072861C publication Critical patent/CA3072861C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne de nouveaux composés d'azaindolylpyridone et de diazaindolylpyridone de formule (I), des compositions pharmaceutiques contenant ces composés, et des procédés d'utilisation de tels composés pour le traitement de maladies, notamment du cancer, du diabète de type II, de maladies inflammatoires, de maladies auto-immunes, de troubles neurodégénératifs, de troubles cardiovasculaires et d'infections virales ; dans la formule, R2, R3 et X sont tels que définis dans la description.
CA3072861A 2017-08-23 2018-08-23 Composes d'azaindolylpyridone et de diazaindolylpyridone Active CA3072861C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17187519 2017-08-23
EP17187519.8 2017-08-23
PCT/EP2018/072785 WO2019038384A1 (fr) 2017-08-23 2018-08-23 Composés d'azaindolylpyridone et de diazaindolylpyridone

Publications (2)

Publication Number Publication Date
CA3072861A1 CA3072861A1 (fr) 2019-02-28
CA3072861C true CA3072861C (fr) 2025-09-16

Family

ID=

Similar Documents

Publication Publication Date Title
AU2018320418B2 (en) Pyridinamine-pyridone and pyrimidinamine-pyridone compounds
KR20140071361A (ko) 피라졸로[3,4-c]피리딘 화합물 및 사용 방법
US20230322772A1 (en) Azaindolylpyridone and diazaindolylpyridone compounds
AU2023258375A1 (en) Pyridylpyridone Compounds
CA3072861C (fr) Composes d'azaindolylpyridone et de diazaindolylpyridone
HK40072566A (en) Azaindolylpyridone and diazaindolylpyridone compounds
RU2788659C2 (ru) Азаиндолилпиридоны и диазаиндолилпиридоны
CA3073142C (fr) Composes de morpholinylpyridone
CA3072974C (fr) Composes de pyridylpyridone
CA3073129C (fr) Composes pyridinamine-pyridone et pyrimidinamine-pyridone
HK40030347B (en) Azaindolylpyridone and diazaindolylpyridone compounds
CA3015045C (fr) Composes 6-aryl-4-morpholin-1-yl-pyridone utilises pour le traitement du cancer et du diabete
CA3073142A1 (fr) Composes de morpholinylpyridone